Plexus Corp. (PLXS) Q1 2025 Filing Summary
Business Context and Reporting Period
This Form 10-Q covers the quarterly period ended December 28, 2024 (Fiscal Q1 2025). Plexus Corp. is a global manufacturer providing design, manufacturing, and service solutions for complex products in the Aerospace/Defense, Healthcare/Life Sciences, and Industrial sectors. The company operates across three geographic segments: Americas (AMER), Asia-Pacific (APAC), and Europe, Middle East, and Africa (EMEA).
Key Financial Metrics
| Metric | Q1 2025 (Dec 28, 2024) | Q1 2024 (Dec 30, 2023) |
|---|---|---|
| Net Sales | $976.1 million | $982.6 million |
| Gross Profit | $100.7 million | $88.1 million |
| Gross Margin | 10.3% | 9.0% |
| Operating Income | $46.9 million | $45.2 million |
| Operating Margin | 4.8% | 4.6% |
| Net Income | $37.3 million | $29.2 million |
| Diluted EPS | $1.34 | $1.04 |
| Operating Cash Flow | $53.6 million | ($3.0) million |
| Free Cash Flow | $27.1 million | ($31.7) million |
| Cash & Equivalents | $317.2 million | $232.4 million (End of Q1 2024) |
| Total Debt Obligations | $210.7 million | $247.3 million (End of Q4 2024) |
Material Changes vs. Prior Period
- Revenue: Net sales decreased 0.7% year-over-year. This was driven by declines in the AMER (-11.6%) and EMEA (-16.6%) segments due to lower end-market demand, partially offset by a 9.8% increase in the APAC segment driven by new product ramps and higher demand.
- Profitability: Gross margin expanded 130 basis points to 10.3%, and operating margin improved 20 basis points to 4.8%. Improvements were driven by a positive shift in customer mix, reduced fixed costs, and productivity gains.
- Restructuring: The company incurred $4.7 million in restructuring and other charges, primarily severance costs for workforce reductions in EMEA and AMER. No such charges were recorded in the prior year period.
- Interest Expense: Decreased by $4.1 million to $3.6 million due to lower borrowings on the credit facility.
- Cash Flow: Operating cash flow turned positive at $53.6 million, a significant improvement from a $3.0 million outflow in the prior year, driven by better working capital management (inventory reduction and accounts payable timing).
Guidance, Outlook, and Risks
- Capital Expenditures: Management estimates fiscal 2025 capital expenditures will range from $120.0 million to $150.0 million, including $60.0 million for a facility expansion in Penang, Malaysia.
- Tax Outlook: The annual effective tax rate for fiscal 2025 is expected to be approximately 14.0% to 16.0%.
- Share Repurchases: Under the "2025 Program," the company repurchased 84,823 shares for $12.8 million. Approximately $37.2 million of authorization remains.
- Risks: Key risks include global economic conditions, supply chain constraints, component shortages, foreign currency fluctuations, and the impact of tariffs and trade disputes. The company notes that 77% of its cash is held outside the U.S.
- Unusual Items: The company recorded a $4.7 million restructuring charge. Additionally, $31.4 million in future cash outflows are expected for U.S. federal taxes on deemed repatriation of foreign earnings over the next two years.
Investor Verification Checklist
- Segment Performance: Verify the sustainability of the APAC growth trend versus the continued demand softness in AMER and EMEA.
- Working Capital Efficiency: Confirm if the 27-day improvement in the annualized cash cycle (down to 68 days) is a one-time benefit of inventory reduction or a structural improvement.
- Restructuring Impact: Monitor the realization of cost savings from the $4.7 million restructuring charge in subsequent quarters.
- Debt Maturity: Note the $100 million 4.05% Senior Notes due June 15, 2025, and assess refinancing plans or repayment sources.
- Customer Concentration: Review the "Risk Factors" section for details on customer concentration risks, particularly given the reliance on specific sectors like Healthcare and Aerospace.